Interferon induced IFIT family genes in host antiviral defense

International Journal of Biological Sciences

Volumn 9, Issue 2, 2013, Pages 200-208

  Zhou, Xiang ^a,b   Michal, Jennifer J ^a   Zhang, Lifan ^a   Ding, Bo ^a   Lunney, Joan K ^c   Liu, Bang ^b   Jiang, Zhihua ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Antiviral activities; Evolution; IFIT family; Regulation and signaling; Therapy of infectious diseases

Indexed keywords

EID: 84873722226     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.5613     Document Type: Review

References (62)

1. de Weerd NA, Samarajiwa SA, Hertzog PJ. Type I interferon receptors: biochemistry and biological functions. J Biol Chem. 2007; 282: 20053-20057.
2. Fensterl V, Sen GC. Interferons and viral infections. Biofactors. 2009; 35: 14-20.
3. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol. 2001; 69: 912-920.
4. D'Andrea LD, Regan L. TPR proteins: the versatile helix. Trends Biochem Sci. 2003; 28: 655-662.
5. Chebath J, Merlin G, Metz R, Benech P, Revel M. Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA. Nucleic Acids Res. 1983; 11: 1213-1226.
6. Kusari J, Sen GC. Transcriptional analyses of interferon-inducible mRNAs. Mol Cell Biol. 1987; 7: 528-531.
7. Fensterl V, Sen GC. The ISG56/IFIT1 gene family. J Interferon Cytokine Res. 2011; 31: 71-78.
8. Gobin SJ, Peijnenburg A, Keijsers V, van den Elsen PJ. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity. 1997; 6: 601-611.
9. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A. 1998; 95: 15623-15628.
10. Zhu H, Cong JP, Shenk T. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc Natl Acad Sci U S A. 1997; 94: 13985-13990.
11. Zhao H, Boije H, Granberg F, Pettersson U, Svensson C. Activation of the interferon-induced STAT pathway during an adenovirus type 12 infection. Virology. 2009; 392: 186-195.
12. Grinde B, Gayorfar M, Rinaldo CH. Impact of a polyomavirus (BKV) infection on mRNA expression in human endothelial cells. Virus Res. 2007; 123: 86-94.
13. Rathi AV, Cantalupo PG, Sarkar SN, Pipas JM. Induction of interferon-stimulated genes by Simian virus 40 T antigens. Virology. 2010; 406: 202-211.
14. Wacher C, Muller M, Hofer MJ, Getts DR, Zabaras R, Ousman SS, et al. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J Virol. 2007; 81: 860-871.
15. Xiao S, Mo D, Wang Q, Jia J, Qin L, Yu X, et al. Aberrant host immune response induced by highly virulent PRRSV identified by digital gene expression tag profiling. BMC Genomics. 2010; 11: 544.
16. Zhou P, Zhai S, Zhou X, Lin P, Jiang T, Hu X, et al. Molecular characterization of transcriptome-wide interactions between highly pathogenic porcine reproductive and respiratory syndrome virus and porcine alveolar macrophages in vivo. Int J Biol Sci. 2011; 7: 947-959.
17. Matthys V, Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER. The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction. J Virol. 2011; 85: 4752-4760.
18. Lietzen N, Ohman T, Rintahaka J, Julkunen I, Aittokallio T, Matikainen S, et al. Quantitative subcellular proteome and secretome profiling of influenza A virus-infected human primary macrophages. PLoS Pathog. 2011; 7: e1001340.
19. Kawada J, Kimura H, Kamachi Y, Nishikawa K, Taniguchi M, Nagaoka K, et al. Analysis of gene-expression profiles by oligonucleotide microarray in children with influenza. J Gen Virol. 2006; 87: 1677-1683.
20. Vanderven HA, Petkau K, Ryan-Jean KE, Aldridge JR, Jr., Webster RG, Magor KE. Avian influenza rapidly induces antiviral genes in duck lung and intestine. Mol Immunol. 2012; 51: 316-324.
21. Saha S, Sugumar P, Bhandari P, Rangarajan PN. Identification of Japanese encephalitis virus-inducible genes in mouse brain and characterization of GARG39/IFIT2 as a microtubule-associated protein. J Gen Virol. 2006; 87: 3285-329.
22. Saha S, Rangarajan PN. Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses. J Gen Virol. 2003; 84: 1729-1735.
23. Ovstebo R, Olstad OK, Brusletto B, Moller AS, Aase A, Haug KB, et al. Identification of genes particularly sensitive to lipopolysaccharide (LPS) in human monocytes induced by wild-type versus LPS-deficient Neisseria meningitidis strains. Infect Immun. 2008; 76: 2685-2695.
24. Berchtold S, Manncke B, Klenk J, Geisel J, Autenrieth IB, Bohn E. Forced IFIT-2 expression represses LPS induced TNF-alpha expression at posttranscriptional levels. BMC Immunol. 2008; 9: 75.
25. Kylaniemi MK, Haveri A, Vuola JM, Puolakkainen M, Lahesmaa R. Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection. Microb Pathog. 2009; 46: 235-242.
26. Li Y, Li C, Xue P, Zhong B, Mao AP, Ran Y, et al. ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response. Proc Natl Acad Sci U S A. 2009; 106: 7945-7950.
27. Liu XY, Chen W, Wei B, Shan YF, Wang C. IFN-induced TPR protein IFIT3 potentiates antiviral signaling by bridging MAVS and TBK1. J Immunol. 2011; 187: 2559-2568.
28. Pichlmair A, Lassnig C, Eberle CA, Gorna MW, Baumann CL, Burkard TR, et al. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat Immunol. 2011; 12: 624-630.
29. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010; 140: 805-820.
30. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11: 373-384.
31. O'Neill LA, Bowie AGz. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007; 7: 353-364.
32. Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci U S A. 2006; 103: 15136-15141.
33. Daffis S, Samuel MA, Keller BC, Gale M, Jr., Diamond MS. Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and -independent mechanisms. PLoS Pathog. 2007; 3: e106.
34. Elco CP, Sen GC. Stat1 required for interferon-inducible but not constitutive responsiveness to extracellular dsRNA. J Interferon Cytokine Res. 2007; 27: 411-424.
35. Zhou X, Jiang T, Du X, Zhou P, Jiang Z, Michal JJ, et al. Molecular characterization of porcine SARM1 and its role in regulating TLRs signaling during highly pathogenic porcine reproductive and respiratory syndrome virus infection in vivo. Dev Comp Immunol. 2012.
36. Kawai T, Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006; 7: 131-137.
37. Hui DJ, Terenzi F, Merrick WC, Sen GC. Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. J Biol Chem. 2005; 280: 3433-3440.
38. Guo J, Hui DJ, Merrick WC, Sen GC. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J. 2000; 19: 6891-6899.
39. Terenzi F, Hui DJ, Merrick WC, Sen GC. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem. 2006; 281: 34064-34071.
40. Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol. 2011; 85: 12881-12889.
41. Saikia P, Fensterl V, Sen GC. The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication. J Virol. 2010; 84: 13036-13039.
42. Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, et al. Interferon-Induced Ifit2/ISG54 Protects Mice from Lethal VSV Neuropathogenesis. PLoS Pathog. 2012; 8: e1002712.
43. Stawowczyk M, Van Scoy S, Kumar KP, Reich NC. The interferon stimulated gene 54 promotes apoptosis. J Biol Chem. 2011; 286: 7257-66.
44. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Immunol Today. 2000; 21: 447-455.
45. Jouan L, Chatel-Chaix L, Melancon P, Rodrigue-Gervais IG, Raymond VA, Selliah S, et al. Targeted impairment of innate antiviral responses in the liver of chronic hepatitis C patients. J Hepatol. 2012; 56: 70-77.
46. Zhu H, Zheng C, Xing J, Wang S, Li S, Lin R, et al. Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3. J Virol. 2011; 85: 11079-11089.
47. Patel D, Nan Y, Shen M, Ritthipichai K, Zhu X, Zhang YJ. Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation. J Virol. 2010; 84: 11045-11055.
48. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, et al. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature. 2010; 468: 452-456.
49. Furuichi Y, Shatkin AJ. Viral and cellular mRNA capping: past and prospects. Adv Virus Res. 2000; 55: 135-184.
50. Flori L, Gao Y, Laloe D, Lemonnier G, Leplat JJ, Teillaud A, et al. Immunity traits in pigs: substantial genetic variation and limited covariation. PLoS One. 2011; 6: e22717.
51. Abe H, Hayes CN, Ochi H, Maekawa T, Tsuge M, Miki D, et al. IL28 variation affects expression of interferon stimulated genes and peg-interferon and ribavirin therapy. J Hepatol. 2011; 54: 1094-1101.
52. Fujimoto Y, Ochi H, Maekawa T, Abe H, Hayes CN, Kumada H, et al. A single nucleotide polymorphism in activated Cdc42 associated tyrosine kinase 1 influences the interferon therapy in hepatitis C patients. J Hepatol. 2011; 54: 629-639.
53. Lopez-Rodriguez R, Trapero-Marugan M, Borque MJ, Roman M, Hernandez-Bartolome A, Rodriguez-Munoz Y, et al. Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C. Clin Pharmacol Ther. 2011; 90: 712-721.
54. Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med. 2007; 147: 677-684.
55. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011; 472: 481-485.
56. Parvizi P, Abdul-Careem MF, Haq K, Thanthrige-Don N, Schat KA, Sharif S. Immune responses against Marek's disease virus. Anim Health Res Rev. 2010; 11: 123-134.
57. Pantin-Jackwood MJ, Swayne DE. Pathogenesis and pathobiology of avian influenza virus infection in birds. Rev Sci Tech. 2009; 28: 113-136.
58. Lunney JK, Chen H. Genetic control of host resistance to porcine reproductive and respiratory syndrome virus (PRRSV) infection. Virus Res. 2010; 154: 161-169.
59. Hong YH, Kim ES, Lillehoj HS, Lillehoj EP, Song KD. Association of resistance to avian coccidiosis with single nucleotide polymorphisms in the zyxin gene. Poult Sci. 2009; 88: 511-518.
60. White SN, Taylor KH, Abbey CA, Gill CA, Womack JE. Haplotype variation in bovine Toll-like receptor 4 and computational prediction of a positively selected ligand-binding domain. Proc Natl Acad Sci U S A. 2003; 100: 10364-10369.
61. Uenishi H, Shinkai H, Morozumi T, Muneta Y, Jozaki K, Kojima-Shibata C, et al. Polymorphisms in pattern recognition receptors and their relationship to infectious disease susceptibility in pigs. BMC Proc. 2011; 5 Suppl 4: S27.
62. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007; 24: 1596-1599.